|
[1]
|
Levine, B.L., Miskin, J., Wonnacott, K. and Keir, C. (2017) Global Manufacturing of CAR T Cell Therapy. Molecular Therapy—Methods & Clinical Development, 4, 92-101. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Russell, S.J., Peng, K. and Bell, J.C. (2012) Oncolytic Virotherapy. Nature Biotechnology, 30, 658-670. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Zamarin, D., Holmgaard, R.B., Subudhi, S.K., Park, J.S., Mansour, M., Palese, P., et al. (2014) Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy. Science Translational Medicine, 6, 226ra32. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Barish, S., Ochs, M.F., Sontag, E.D. and Gevertz, J.L. (2017) Evaluating Optimal Therapy Robustness by Virtual Expansion of a Sample Population, with a Case Study in Cancer Immunotherapy. Proceedings of the National Academy of Sciences of the United States of America, 114, E6277-E6286. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Martuza, R.L., Malick, A., Markert, J.M., Ruffner, K.L. and Coen, D.M. (1991) Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant. Science, 252, 854-856. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Kochneva, G.V., Sivolobova, G.F., Tkacheva, A.V., Gorchakov, A.A. and Kulemzin, S.V. (2020) Combination of Oncolytic Virotherapy and CAR T/NK Cell Therapy for the Treatment of Cancer. Molecular Biology, 54, 1-12. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Nishio, N. and Dotti, G. (2015) Oncolytic Virus Expressing RANTES and IL-15 Enhances Function of Car-Modified T Cells in Solid Tumors. OncoImmunology, 4, e988098. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Park, A.K., Fong, Y., Kim, S., Yang, J., Murad, J.P., Lu, J., et al. (2020) Effective Combination Immunotherapy Using Oncolytic Viruses to Deliver CAR Targets to Solid Tumors. Science Translational Medicine, 12, eaaz1863. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Walker, R., Navas, P.E., Friedman, S.H., Galliani, S., Karolak, A., Macfarlane, F., Noble, R., Poleszczuk, J., Russell, S., Rejniak, K.A., et al. (2016) Enhancing Synergy of CAR T Cell Therapy and Oncolytic Virus Therapy for Pancreatic Cancer. bioRxiv: 055988.
|
|
[10]
|
Mahasa, K.J., Ouifki, R., Eladdadi, A. and Pillis, L.D. (2022) A Combination Therapy of Oncolytic Viruses and Chimeric Antigen Receptor T Cells: A Mathematical Model Proof-of-Concept. Mathematical Biosciences and Engineering, 19, 4429-4457. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Renshaw, E. (1993) Modelling Biological Populations in Space and Time. Cambridge University Press.
|
|
[12]
|
Singh, A., Razooky, B., Cox, C.D., Simpson, M.L. and Weinberger, L.S. (2010) Transcriptional Bursting from the HIV-1 Promoter Is a Significant Source of Stochastic Noise in HIV-1 Gene Expression. Biophysical Journal, 98, L32-L34. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
王欣笛, 梅恒, 胡豫. 血液肿瘤嵌合抗原受体自然杀伤细胞治疗研究进展[J]. 中华血液学杂志, 2022, 43(12): 1051-1056.
|
|
[14]
|
Lee, D.A. (2019) Cellular Therapy: Adoptive Immunotherapy with Expanded Natural Killer Cells. Immunological Reviews, 290, 85-99. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
胡冰. 带有溶瘤病毒治疗的随机肿瘤生长模型的动力学研究[D]: [硕士学位论文]. 长春: 东北师范大学, 2022.
|
|
[16]
|
Khasminskii, R. (2011) Stochastic Stability of Differential Equations, Volume 66. Springer Science & Business Media.
|
|
[17]
|
Higham, D.J. (2001) An Algorithmic Introduction to Numerical Simulation of Stochastic Differential Equations. SIAM Review, 43, 525-546. [Google Scholar] [CrossRef]
|